The XRCC1 399Gln allele has been linked with a reduced risk of colorectal adenomas [12,13], and XRCC1 has also been associated with improved progress in patients who underwent chemotherapy, but not in those who received surgery alone [11]. This evidence concerns the gene XRCC1 and colorectal adenoma.